Advanced search

News (32)

Bachem : Annual Report EN	Mar. 07	PU
Transcript : Bachem Holding AG, 2023 Earnings Call, Mar 07, 2024	Mar. 07
Bachem : reorganizes responsibilities in the Corporate Executive Committee and increases focus on capacity expansion and efficiency improvement	23-09-15	PU
Spexis announces the results of its Annual General Meeting 2023	23-06-26	EQ
Spexis : Invitation AGM 2023	23-06-07	PU
Bachem : Presentation Capital Markets Day 2022	22-09-20	PU
Spexis : Corporate Presentation June 2022	22-06-01	PU
Bachem : Annual General Meeting 2022	22-04-27	PU
Spexis Annual General Meeting 2022	22-04-27	EQ
Spexis : Invitation AGM 2022 (PDF)	22-03-31	PU
Polyphor closes merger with EnBiotix and is renamed Spexis	21-12-30	EQ
EnBiotix, Inc. completed the acquisition of Polyphor AG from Novartis Venture Funds, Varuma AG, Novo Holdings A/S and others in a reverse merger transaction.	21-12-28	CI
Polyphor AG Announces Executive Changes	21-10-29	CI
Transcript : Polyphor AG - Special Call	21-10-14
EnBiotix, Inc. signed a merger agreement to acquire Polyphor AG from Novartis Venture Funds, Varuma AG, Novo Holdings A/S and others in a reverse merger transaction.	21-08-31	CI
Bachem : innovating through virtual events	21-06-28	PU
Bachem : A world market leader from the Basel region – Bachem celebrates 50 years of company history	21-06-15	PU
Polyphor : Annual General Meeting 2021	21-04-06	PU
Transcript : Polyphor AG - Special Call	21-03-22
Polyphor : shareholders approve all proposals at the Annual General Meeting 2020	20-06-05	AQ
Polyphor : shareholders approve all proposals at the Annual General Meeting 2020	20-06-04	EQ
Polyphor : publishes invitation to the Annual General Meeting 2020	20-05-06	AQ
Polyphor : publishes invitation to the Annual General Meeting 2020	20-05-05	EQ
Polyphor : appoints Gokhan Batur as Chief Executive Officer	20-01-24	AQ
Polyphor : appoints Gökhan Batur as Chief Executive Officer	20-01-23	EQ
Polyphor : announces changes to its Board of Directors	19-11-20	EQ
Polyphor : announces changes to its Board of Directors	19-11-20	PU
Polyphor Ag Announces Management Changes	19-11-20	CI
Polyphor : shareholders approve all motions proposed by the Board of Directors at the Annual General Meeting	19-04-12	EQ
Bachem : expands its Corporate Executive Committee	17-02-24	PU
BACHEM : Dr. Guenther Loidl to assume CTO position at Bachem Group	14-08-25	PU
Polyphor Ltd Announces Board Changes	13-06-10	CI

Insiders

Kuno Sommer

Dr. Kuno Sommer is a Chairman at Targimmune Therapeutics AG, a Chairman-Supervisory Board at Sunstar-Holding AG, a Chairman at Polyphor AG, a Chairman at Bachem Holding AG, a Chairman at PDS Pathology Data Systems Co. Ag, a Chairman at Kenta Biotech AG and a Chairman at Bachem Americas, Inc. He is on the Board of Directors at Ferienclub Privilège AG. Dr. Sommer was previously employed as a Chief Executive Officer by Harlan Laboratories Ltd., a Chief Executive Officer by Berna Biotech AG, a Chief Executive Officer by Givaudan SA, a Principal by F. Hoffmann-La Roche Ltd., a Chief Business Officer by Crucell NV, a Head-Contract Research by Harlan Laboratories Ltd., a Chairman by Pevion Biotech AG, and a Member-Executive Committee by Roche Holding AG. He received his MBA from the University of Basel and a doctorate degree from the University of Basel.

Hitoshi Kuno

Hitoshi Kuno currently works at Nittoku Co., Ltd., as Senior Managing Representative Director from 2020, Nittoku Kosei Co., Ltd., as President & Representative Director from 2008, and Nittoku Koide Co., Ltd., as Director from 2014.

No results for this search